// App-Quantinova.ai

PB1743 : EXPERIENCES AND SUPPORT NEEDS OF CAREGIVERS OF PATIENTS WITH HIGHER-RISK MDS: QUALITATIVE INSIGHTS VIA ONLINE BULLETIN BOARD IN THE US, UK, AND CANADA

Researchers

Presenter

  • Pauline Frank MSc

Principal Investigators

  • Anne S Olshan

  • Tracey Iraca

  • Cindy Anthony

  • Sophie Wintrich

  • Emma Sasse

Medical Centers

  • Myelodysplastic Syndromes Foundation US,Yardville,United States

  • Olshan Patient Relations Inc,Stamford,United States

  • MDS UK Support Group, London, United Kingdom

  • Novartis Pharma Corp, Basel, Switzerland

  • Myelodysplasia Association ,Ontario,Canada

  • Aplastic Anemia &amp

Locations

  • United States

  • United Kingdom

  • Switzerland

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Coronavirus disease

Biomarkers

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved